Variation in RARG increases susceptibility to doxorubicin-induced cardiotoxicity in patient specific induced pluripotent stem cell-derived cardiomyocytes

Doxorubicin is a potent anticancer drug used to treat a variety of cancer types. However, its use is limited by doxorubicin-induced cardiotoxicity (DIC). A missense variant in the RARG gene (S427L; rs2229774) has been implicated in susceptibility to DIC in a genome wide association study. The goal o...

Descripción completa

Detalles Bibliográficos
Autores principales: Christidi, Effimia, Huang, Haojun, Shafaattalab, Sanam, Maillet, Agnes, Lin, Eric, Huang, Kate, Laksman, Zachary, Davis, Margot K., Tibbits, Glen F., Brunham, Liam R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316788/
https://www.ncbi.nlm.nih.gov/pubmed/32587261
http://dx.doi.org/10.1038/s41598-020-65979-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316788/
https://www.ncbi.nlm.nih.gov/pubmed/32587261
http://dx.doi.org/10.1038/s41598-020-65979-x

Ejemplares similares